Literature DB >> 22217000

Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.

Laura Connelly1, Hyunbum Jang, Fernando Teran Arce, Ricardo Capone, Samuel A Kotler, Srinivasan Ramachandran, Bruce L Kagan, Ruth Nussinov, Ratnesh Lal.   

Abstract

Alzheimer's disease (AD) is a protein misfolding disease characterized by a buildup of β-amyloid (Aβ) peptide as senile plaques, uncontrolled neurodegeneration, and memory loss. AD pathology is linked to the destabilization of cellular ionic homeostasis and involves Aβ peptide-plasma membrane interactions. In principle, there are two possible ways through which disturbance of the ionic homeostasis can take place: directly, where the Aβ peptide either inserts into the membrane and creates ion-conductive pores or destabilizes the membrane organization, or, indirectly, where the Aβ peptide interacts with existing cell membrane receptors. To distinguish between these two possible types of Aβ-membrane interactions, we took advantage of the biochemical tenet that ligand-receptor interactions are stereospecific; L-amino acid peptides, but not their D-counterparts, bind to cell membrane receptors. However, with respect to the ion channel-mediated mechanism, like L-amino acids, D-amino acid peptides will also form ion channel-like structures. Using atomic force microscopy (AFM), we imaged the structures of both D- and L-enantiomers of the full length Aβ(1-42) when reconstituted in lipid bilayers. AFM imaging shows that both L- and D-Aβ isomers form similar channel-like structures. Molecular dynamics (MD) simulations support the AFM imaged 3D structures. Previously, we have shown that D-Aβ(1-42) channels conduct ions similarly to their L- counterparts. Taken together, our results support the direct mechanism of Aβ ion channel-mediated destabilization of ionic homeostasis rather than the indirect mechanism through Aβ interaction with membrane receptors.
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22217000      PMCID: PMC4342054          DOI: 10.1021/jp2108126

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  53 in total

1.  Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity.

Authors:  R Bhatia; H Lin; R Lal
Journal:  FASEB J       Date:  2000-06       Impact factor: 5.191

Review 2.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

3.  An ab initio study on the torsional surface of alkanes and its effect on molecular simulations of alkanes and a DPPC bilayer.

Authors:  Jeffery B Klauda; Bernard R Brooks; Alexander D MacKerell; Richard M Venable; Richard W Pastor
Journal:  J Phys Chem B       Date:  2005-03-24       Impact factor: 2.991

4.  Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

Authors:  H Lin; R Bhatia; R Lal
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

5.  Amyloid β peptides aggregation in a mixed membrane bilayer: a molecular dynamics study.

Authors:  Li Na Zhao; See-Wing Chiu; Jérôme Benoit; Lock Yue Chew; Yuguang Mu
Journal:  J Phys Chem B       Date:  2011-10-05       Impact factor: 2.991

6.  Models of membrane-bound Alzheimer's Abeta peptide assemblies.

Authors:  Yinon Shafrir; Stewart Durell; Nelson Arispe; H Robert Guy
Journal:  Proteins       Date:  2010-10-11

7.  Structural convergence among diverse, toxic beta-sheet ion channels.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Ricardo Capone; Ratnesh Lal; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2010-07-29       Impact factor: 2.991

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity.

Authors:  Giuseppe D Ciccotosto; Deborah J Tew; Simon C Drew; Danielle G Smith; Timothy Johanssen; Varsha Lal; Tong-Lay Lau; Keyla Perez; Cyril C Curtain; John D Wade; Frances Separovic; Colin L Masters; Jeffrey P Smith; Kevin J Barnham; Roberto Cappai
Journal:  Neurobiol Aging       Date:  2009-03-25       Impact factor: 4.673

10.  Amyloidosis of Alzheimer's Abeta peptides: solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies.

Authors:  Oleg N Antzutkin
Journal:  Magn Reson Chem       Date:  2004-02       Impact factor: 2.447

View more
  47 in total

1.  The higher level of complexity of K-Ras4B activation at the membrane.

Authors:  Hyunbum Jang; Avik Banerjee; Tanmay S Chavan; Shaoyong Lu; Jian Zhang; Vadim Gaponenko; Ruth Nussinov
Journal:  FASEB J       Date:  2015-12-30       Impact factor: 5.191

2.  Familial Alzheimer's disease Osaka mutant (ΔE22) β-barrels suggest an explanation for the different Aβ1-40/42 preferred conformational states observed by experiment.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Bruce L Kagan; Ratnesh Lal; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2013-09-13       Impact factor: 2.991

3.  Mechanism of membrane permeation induced by synthetic β-hairpin peptides.

Authors:  Kshitij Gupta; Hyunbum Jang; Kevin Harlen; Anu Puri; Ruth Nussinov; Joel P Schneider; Robert Blumenthal
Journal:  Biophys J       Date:  2013-11-05       Impact factor: 4.033

Review 4.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

5.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

6.  Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology.

Authors:  An T Dao; Munder A Zagaar; Amber T Levine; Samina Salim; Jason L Eriksen; Karim A Alkadhi
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

Review 7.  Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Bruce L Kagan; Ratnesh Lal; Ruth Nussinov
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

8.  Molecular interactions of Alzheimer amyloid-β oligomers with neutral and negatively charged lipid bilayers.

Authors:  Xiang Yu; Qiuming Wang; Qingfen Pan; Feimeng Zhou; Jie Zheng
Journal:  Phys Chem Chem Phys       Date:  2013-03-14       Impact factor: 3.676

Review 9.  Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

Authors:  Hyunbum Jang; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Bruce L Kagan; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2013-02-28       Impact factor: 3.676

10.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.